Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo

By | February 24, 2021
A team of researchers examined PT150, which is an allosteric modulator of androgen and glucocorticoid receptors, to assess whether it had any antiviral activity or immunomodulatory activity to decrease the hyperinflammatory response of SARS-CoV-2 infection.